Come on all. A drug that's good look at AERI today nice jump on news. Baker brothers have a good background holding winners. I'm disappointed ted trust me I bough some at 50 in 2015! But just a feeling. I bought Jazz at 3 in 2009. I'm not saying it will jump to 190 like Jazz hit in summer 2015 before the Hillary biotech explosion but I see it at 100. Bought Medivation and bought out and think this will be also. Execs are not as good as the Medivation team but I like it.
I hate this stock. Red red red.
This Titanic is sinking, if you haven't abandoned ship, then may your portfolio rest peacefully at the bottom.
slow bleed every day.
This appears to be a great company, but if they keep making decisions for the long-term, the price will continue to drop because too many investors are only interested in the buyout.
Baker bros still own this junk? 😱
Big Money Rif
This stock is garbage. They should of sold this company by now.
Stop listening to the bashers Been in ACAD for a couple years, if you don't believe in management and the product, you will beat yourself up There being very very safe
Interesting. Time to decide if you're in ACAD for the long haul. Biotech is out of favor right now.
Positive Clinical Results Ahead For Acadia Pharmaceuticals
Shares of Acadia fell after the company reported quarterly results. Investors are disappointed the company did not announce a buyout. Fundamentals are strong as
A drop of $13 dollars in 2 months, that's a lot. It looks like shareholders are losing confidence. It could be $19 in another month. Those analysts posting their reviews from 2 months ago were correct when they estimated that the pricing would drop.
Do you think this thing is done selling? Showing us a buy signal now on ACAD? Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from awesomeS-TOCKS.
Shares of Acadia Pharmaceuticals are tanking this morning, but that could be a great buying opportunity.
Recommendation - MODN. Under the radar RX software. Very little downside right now
Ry asked me to share my investment thesis here on Antares Pharma, ATRS. Antares is up over 100% in the past year and recently analysts have projected it will rocket from its current 2.50 price to $15 per share with current product approvals. Near term ATRS is expecting FDA approval for EPI pen with Teva as well as Exenatide. Currently also awaiting approval for Makena which is a partnered product with AMAG. The largest current pending product approval is QST which has a PDUFA date in October for injectable testosterone. Please do your own DD but this is well worth the look.
could this movement south starting from 42 $ to ........ a drop to many ???? no bad news last couple months and yet again a huge drop ..... what if there publish 1 little tiny bad news article we drop to 12 $ ?????? maybe then we get lucky and there is a little intrest in buying out at 28$ (lol)
Small possibility of a morning star formation which might signal a green day tomorrow. But past patterns like this still resulted in lower share price. Caution with your buys. GLTA
Against my better judgment, I'm doubling down.
Because my better judgment is always wrong.
At the end of the conf call last, big daddy said something to the effect of 'Thanks for hanging in there with us' That doesn't strike me as something the captain of a sinking ship would say. I read those weed leaves as "thanks for you patience, it will be rewarded" Does anybody know how to gauge off label scripts for this drug?